These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5789805)

  • 1. The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.
    Rogers KJ; Thornton JA
    Br J Pharmacol; 1969 Jul; 36(3):470-80. PubMed ID: 5789805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification by monoamine oxidase inhibitors of the analgesic, hypothermic and toxic actions of morphine and pethidine in mice.
    Botting R; Bower S; Eason CT; Hutson PH; Wells L
    J Pharm Pharmacol; 1978 Jan; 30(1):36-40. PubMed ID: 22722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the analgetic effects of MAO inhibitors].
    Fähse C; Matthies H
    Acta Biol Med Ger; 1971; 26(6):1215-21. PubMed ID: 5153309
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R; Botting R; Coulson P; Spanswick G
    Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of butorphanol, with monoamine oxidase inhibitor, tranylcypromine.
    Gomaa AA; Mohammed LH; Ahmed HN; Farghaly AM
    Forensic Sci Int; 1991 Mar; 49(2):185-92. PubMed ID: 1855717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Förster W; Gräbner S
    Acta Biol Med Ger; 1966; 16(6):650-7. PubMed ID: 4383660
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of pethidine and morphine in the presence of monoamine oxidase inhibitors.
    Evans-Prosser CD
    Br J Anaesth; 1968 Apr; 40(4):279-82. PubMed ID: 5654977
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between histamine and monoamine oxidase inhibitors.
    Allen GS; Rand MJ
    J Pharm Pharmacol; 1969 May; 21(5):317-22. PubMed ID: 4390125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors].
    Goldwurm GF; Torrigiani G
    Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE ANALGESIC PROPERTIES OF MONOAMINE OXIDASE INHIBITORS].
    ZABOJNIKOVA M; KOVALCIK V
    Cas Lek Cesk; 1963 May; 102():511-4. PubMed ID: 14073552
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of morphine, pethidine and pentazocine in rabbits pretreated with a monoamine oxidase inhibitor.
    Penn RG; Rogers KJ
    Br J Pharmacol; 1971 Jul; 42(3):485-92. PubMed ID: 5560905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacologic effect on the adrenergic mechanisms of heart blood supply regulation].
    Zakusov VV; Kaverina NV
    Kardiologiia; 1967 Nov; 7(11):45-54. PubMed ID: 4979866
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine oxidase and cerebral uptake of dopaminergic drugs.
    Cotzias GC; Tang LC; Ginos JZ
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2715-9. PubMed ID: 4137067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.
    Coutts RT; Rao TS; Baker GB; Micetich RG; Hall TW
    Cell Mol Neurobiol; 1987 Sep; 7(3):271-90. PubMed ID: 3440283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.